143 related articles for article (PubMed ID: 27894082)
1. The disintegrin echistatin in combination with doxorubicin targets high-metastatic human osteosarcoma overexpressing ανβ3 integrin in chick embryo and nude mouse models.
Tome Y; Kimura H; Sugimoto N; Tsuchiya H; Kanaya F; Bouvet M; Hoffman RM
Oncotarget; 2016 Dec; 7(52):87031-87036. PubMed ID: 27894082
[TBL] [Abstract][Full Text] [Related]
2. Disintegrin targeting of an αvβ3 integrin-over-expressing high-metastatic human osteosarcoma with echistatin inhibits cell proliferation, migration, invasion and adhesion in vitro.
Tome Y; Kimura H; Kiyuna T; Sugimoto N; Tsuchiya H; Kanaya F; Bouvet M; Hoffman RM
Oncotarget; 2016 Jul; 7(29):46315-46320. PubMed ID: 27331872
[TBL] [Abstract][Full Text] [Related]
3. High lung-metastatic variant of human osteosarcoma cells, selected by passage of lung metastasis in nude mice, is associated with increased expression of α(v)β(3) integrin.
Tome Y; Kimura H; Maehara H; Sugimoto N; Bouvet M; Tsuchiya H; Kanaya F; Hoffman RM
Anticancer Res; 2013 Sep; 33(9):3623-7. PubMed ID: 24023288
[TBL] [Abstract][Full Text] [Related]
4. Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells.
Duan X; Jia SF; Zhou Z; Langley RR; Bolontrade MF; Kleinerman ES
Clin Exp Metastasis; 2004; 21(8):747-53. PubMed ID: 16035619
[TBL] [Abstract][Full Text] [Related]
5. An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model.
Oshiro H; Tome Y; Miyake K; Higuchi T; Sugisawa N; Kanaya F; Nishida K; Hoffman RM
Sci Rep; 2021 Apr; 11(1):8583. PubMed ID: 33883561
[TBL] [Abstract][Full Text] [Related]
6. Antimetastatic Efficacy of the Combination of Caffeine and Valproic Acid on an Orthotopic Human Osteosarcoma Cell Line Model in Nude Mice.
Igarashi K; Kawaguchi K; Kiyuna T; Murakami T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Hoffman RM
Anticancer Res; 2017 Mar; 37(3):1005-1011. PubMed ID: 28314258
[TBL] [Abstract][Full Text] [Related]
7. Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.
Gvozdenovic A; Boro A; Meier D; Bode-Lesniewska B; Born W; Muff R; Fuchs B
Oncotarget; 2016 Aug; 7(34):55141-55154. PubMed ID: 27409827
[TBL] [Abstract][Full Text] [Related]
8. Imaging the interaction of α
Tome Y; Kiyuna T; Uehara F; Bouvet M; Tsuchiya H; Kanaya F; Hoffman RM
J Cell Biochem; 2019 Jan; 120(1):283-289. PubMed ID: 30145815
[TBL] [Abstract][Full Text] [Related]
9. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.
Luu HH; Kang Q; Park JK; Si W; Luo Q; Jiang W; Yin H; Montag AG; Simon MA; Peabody TD; Haydon RC; Rinker-Schaeffer CW; He TC
Clin Exp Metastasis; 2005; 22(4):319-29. PubMed ID: 16170668
[TBL] [Abstract][Full Text] [Related]
10. Imaging the inhibition by anti-β1 integrin antibody of lung seeding of single osteosarcoma cells in live mice.
Kimura H; Tome Y; Momiyama M; Hayashi K; Tsuchiya H; Bouvet M; Hoffman RM
Int J Cancer; 2012 Nov; 131(9):2027-33. PubMed ID: 22323248
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft.
Natarajan A; Ramachandran B; Gopisetty G; Jayavelu S; Sundersingh S; Rajkumar T
Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):361-371. PubMed ID: 33015747
[TBL] [Abstract][Full Text] [Related]
12. [Theranostics of osteosarcoma and lung metastasis with new integrin α
Sui J; Shao G; Zhang L; Zhang P; Bu T; Yao Q; Wang L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2019 Feb; 33(2):170-176. PubMed ID: 30739410
[TBL] [Abstract][Full Text] [Related]
13. Use of αv Integrin Linked to Green Fluorescent Protein in Osteosarcoma Cells and Confocal Microscopy to Image Molecular Dynamics During Lung Metastasis in Nude Mice.
Tome Y; Yano S; Sugimoto N; Mii S; Uehara F; Miwa S; Bouvet M; Tsuchiya H; Kanaya F; Hoffman RM
Anticancer Res; 2016 Aug; 36(8):3811-6. PubMed ID: 27466481
[TBL] [Abstract][Full Text] [Related]
14. Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma.
Yin F; Wang Z; Jiang Y; Zhang T; Wang Z; Hua Y; Song Z; Liu J; Xu W; Xu J; Cai Z; Ding J
Nanomedicine; 2020 Jan; 23():102085. PubMed ID: 31442580
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.
Zhao Y; Tu MJ; Yu YF; Wang WP; Chen QX; Qiu JX; Yu AX; Yu AM
Biochem Pharmacol; 2015 Dec; 98(4):602-13. PubMed ID: 26518752
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma.
González-Fernández Y; Brown HK; Patiño-García A; Heymann D; Blanco-Prieto MJ
Cancer Lett; 2018 Aug; 430():193-200. PubMed ID: 29802930
[TBL] [Abstract][Full Text] [Related]
17. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Tan ML; Friedhuber AM; Dass CR
J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
[TBL] [Abstract][Full Text] [Related]
18. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Maschek G; Savaraj N; Priebe W; Braunschweiger P; Hamilton K; Tidmarsh GF; De Young LR; Lampidis TJ
Cancer Res; 2004 Jan; 64(1):31-4. PubMed ID: 14729604
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet.
Nobuto H; Sugita T; Kubo T; Shimose S; Yasunaga Y; Murakami T; Ochi M
Int J Cancer; 2004 Apr; 109(4):627-35. PubMed ID: 14991586
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor necrosis factor therapy inhibits lung metastasis in an osteosarcoma cell line.
Kato H; Wakabayashi H; Naito Y; Kato S; Nakagawa T; Matsumine A; Sudo A
Oncology; 2015; 88(3):139-46. PubMed ID: 25402182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
